Cassie M. Chandler
Researcher
Also affiliated: University of Kentucky (1977–2024); Albert B. Chandler Hospital (2022); University of Mississippi Medical Center (2017–2021)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Cassie M. Chandler's research investigates the impact of adolescent alcohol exposure on animal models, with a focus on neuroinflammation and subsequent drinking behaviors in adult rats. Her work has examined the effects of intermittent ethanol exposure, social isolation, and oral gavage administration on adult alcohol intake and co-use of alcohol and nicotine. Chandler also studies the role of microglia in the neurodevelopmental consequences of adolescent alcohol consumption. Her recent publications include investigations into the effects of glucocorticoid receptor antagonists on fentanyl self-administration and the targeting of adrenergic receptors for fentanyl-induced depression. She has published 18 papers with an h-index of 8 and 147 citations.
Metrics
- h-index: 8
- Publications: 18
- Citations: 156
Selected Publications
-
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats (2024)
-
The effect of bethanechol on tracheobronchomalacia in infants: A retrospective cohort study (2023)
Collaboration Network
Top Collaborators
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
Similar Researchers
Based on overlapping research topics